• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for AstraZeneca

AstraZeneca

Bodywork: Which Covid-19 vaccine is best?

December 22, 2020

The short answer is: They’re all good. Now here’s the long answer.

Filed Under: Bodywork, COVID-19 News Tagged With: adam, AstraZeneca, best, body, bodywork, cohen, corona, coronavirus, covid, covid-19, FDA, mRNA, Pandemic, Pfizer, Prescott, stephen, steve, vaccine, vax, virus, which, work

Bodywork: Pressing pause on a coronavirus vaccine trial

September 15, 2020

Last week, the drug company AstraZeneca halted its SARS-CoV-2 vaccine trial. What happened?

Filed Under: Bodywork, COVID-19 News Tagged With: adam, adverse, AstraZeneca, body work, bodywork, clinical, cohen, column, coronavirus, covid, covid-19, halt, newsok, NIH, OKC, Oklahoma Medical Research Foundation, oklahoman, OMRF, Pandemic, paper, pause, Prescott, president, stephen, steve, stop, trial, vaccine, virus

OMRF hosts national biotechnology forum

April 4, 2017

Visiting attendees represented some of the top names in in the industry.

Filed Under: News, Technology Ventures News Tagged With: 2017, 5am, abbvie, AstraZeneca, biotechnology, BioVenture, business, collaboration, commercialization, discovery, drug companies, forge, forum, industry, investment, joseph miletich, keynote, Lijun, Lijun Xia, lilly ventures, Mayo Clinic, merck, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, partner, Pfizer, research, science, scientist-news, stephen prescott, technology, technology ventures, Xia

Venture capital, biotech execs converge on OMRF

April 8, 2015

Networking, lab tours highlight first OMRF BioVenture Forum

Filed Under: News, Research News Tagged With: AstraZeneca, biotech, BioVenture, BioVenture Forum, Charles, charles esmon, Congressman Tom Cole, Craig Wegner, Crescendo Bioscience, diagnostics, Esmon, Gene Liau, Gov Mary Fallin, Manu Nair, Nair, OMRF BioVenture Forum 2015, Pfizer, pharma, pharmaceutical, scientist-news, technology ventures, venture capital, William Hagstrom

Staying Alive: Can an experimental OMRF drug stop Mike’s brain cancer?

Doctors exhausted conventional treatments for Mike Schuster. Can an experimental OMRF drug stop his brain cancer? *** In the summer of 2010, Mike and Teresa Schuster took their two boys to Mexico’s Yucatan Peninsula. The Schusters live in Norman, where Teresa is an administrative assistant in the University of Oklahoma’s Office of Student Affairs and […]

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace